Talphera
ACRX · NASDAQ
$1.07−$0.01 (−0.93%)TodayMarket closed ·
Prev close $1.08
Revenue by product and region
Fiscal year ended Dec 31, 2019: $2.29M total revenue
By product
- Product [Member]$1.83M79.9%
- Amended License Agreement [Member]$1.50M65.4%
- ZALVISO [Member]$1.45M63.5%
- Contract and Other Collaboration [Member]$459.00K20.1%
- DSUVIA [Member]$377.00K16.5%
- Other$459.00K20.1%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Zimmer Biomet Holdings ZBH | Supplier and customer | 0.94 |
| Aguettant Sante SA | Supplier and customer | — |
| United States | Customer | — |
| Grunenthal Pharma GmbH & Co. KG | Customer | — |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.